☆ 4.5 Article

SARS-CoV-2-Na?ve Korean Children and Adolescents Hospitalized With COVID-19 in 2021

JOURNAL OF KOREAN MEDICAL SCIENCE (2022)

Related references

Note: Only part of the references are listed.

Article Infectious Diseases

Comparison of the clinical characteristics and outcomes of COVID-19 in children before and after the emergence of Delta variant of concern in Japan

Kensuke Shoji et al.

Summary: This study aimed to investigate the clinical features and outcomes of pediatric patients with COVID-19 infected by the Delta variant. The results showed that although there was a higher admission rate to the intensive care unit in the Delta VOC era, the overall outcomes in children with COVID-19 remained favorable.

JOURNAL OF INFECTION AND CHEMOTHERAPY (2022)

Add to Collection

Review Medicine, General & Internal

Risk Factors for Severe COVID-19 in Children: A Systematic Review and Meta-Analysis

Jae Hong Choi et al.

Summary: This study aimed to identify risk factors for severe COVID-19 in children and provide guidance for hospital admission and vaccination priority. The study found that comorbidities such as obesity, diabetes, heart disease, chronic lung diseases, neonates, and premature infants were associated with a higher prevalence of severe COVID-19 in children.

JOURNAL OF KOREAN MEDICAL SCIENCE (2022)

Add to Collection

Article Medicine, General & Internal

Analysis of Critical COVID-19 Cases Among Children in Korea

Hyunju Lee et al.

Summary: Critical COVID-19 cases in children are rare but can occur, especially in children with obesity and underlying diseases. Treatment for critical cases includes medication and mechanical ventilation. Monitoring the clinical burden of COVID-19 in children is crucial for developing appropriate policies.

JOURNAL OF KOREAN MEDICAL SCIENCE (2022)

Add to Collection

Article Infectious Diseases

Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study

Anika Singanayagam et al.

Summary: Vaccination reduces the risk of delta variant infection and accelerates viral clearance. However, fully vaccinated individuals with breakthrough infections may still have similar peak viral loads as unvaccinated cases and can efficiently transmit the infection.

LANCET INFECTIOUS DISEASES (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Risk factors for PICU admission and death among children and young people hospitalized with COVID-19 and PIMS-TS in England during the first pandemic year

J. L. Ward et al.

Summary: The risk of intensive care unit admission among children with COVID-19 or PIMS-TS is influenced by age, ethnicity, and comorbidities, which can guide treatment and prevention strategies.

NATURE MEDICINE (2022)

Add to Collection

Letter Immunology

Features of COVID-19 Among Children and Adolescents Without Risk Factors Before and After the Delta Variant Outbreak in South Korea

Byung-Han Ryu et al.

PEDIATRIC INFECTIOUS DISEASE JOURNAL (2022)

Add to Collection

Article Pediatrics

Comorbidities Associated with Hospitalization and Progression Among Adolescents with Symptomatic Coronavirus Disease 2019

Jeffrey Campbell et al.

Summary: This study aims to identify subgroups of US adolescents with symptomatic COVID-19 who are likely to benefit from monoclonal antibody and antiviral therapy by evaluating the relationship between comorbidities and hospitalization. The results show that sickle cell disease, immunocompromising conditions, obesity, diabetes, neurologic disease, and pulmonary disease (excluding mild asthma) are associated with increased odds of hospitalization. Adolescents with acute COVID-19 and these comorbidities should be prioritized for therapy to prevent hospitalization.

JOURNAL OF PEDIATRICS (2022)

Add to Collection

Article Pediatrics

Severity of Acute COVID-19 in Children <18 Years Old March 2020 to December 2021

Christopher B. Forrest et al.

Summary: Although there is a risk of moderate to severe illness among children infected with the SARS-CoV-2 virus, the risk of severe disease did not change with the emergence of the Delta variant, despite its high transmissibility.

PEDIATRICS (2022)

Add to Collection

Article Public, Environmental & Occupational Health

Decreased risk of COVID-19 pneumonia in children and adolescents during the Delta variant emergence

E. Murillo-Zamora et al.

Summary: This retrospective nationwide cohort study in Mexico evaluated the risk factors associated with COVID-19 pneumonia in children and adolescents. The study found that during the Delta variant emergence, there was a reduced risk of COVID-19 pneumonia in this population. Older age and cases occurring in May 2021 or later were associated with a lower risk of pneumonia.

PUBLIC HEALTH (2022)

Add to Collection

Letter Pediatrics

Risk of hospitalisation and death in children with SARS-CoV-2 delta (B.1.612.2) infection

Simon Thelwall et al.

LANCET CHILD & ADOLESCENT HEALTH (2022)

Add to Collection

Review Medicine, General & Internal

Which children and young people are at higher risk of severe disease and death after hospitalisation with SARS-CoV-2 infection in children and young people: A systematic review and individual patient meta-analysis

Rachel Harwood et al.

Summary: This study aimed to describe pre-existing factors associated with severe disease and death in hospitalized children and young people with SARS-CoV-2 infection. The study found that infants, teenagers, individuals with cardiac or neurological conditions, those with two or more comorbid conditions, and the obese were at the highest risk for severe disease or death.

ECLINICALMEDICINE (2022)

Add to Collection

Article Infectious Diseases

COVID-19 trends and severity among symptomatic children aged 0-17 years in 10 European Union countries, 3 August 2020 to 3 October 2021

Nick Bundle et al.

Summary: The study estimated risks of severe outcomes in over 820,000 symptomatic pediatric COVID-19 cases reported by 10 EU countries between August 2020 and October 2021. Although individual risks increased for cases with comorbidities, the majority of hospitalized children did not have any comorbidities. Severe outcomes such as hospitalization, intensive care, and death were rare among pediatric COVID-19 cases.

EUROSURVEILLANCE (2021)

Add to Collection

Article Medicine, General & Internal

BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting

Noa Dagan et al.

Summary: A study conducted in Israel on nearly 600,000 individuals showed that the BNT162b2 mRNA vaccine was effective in reducing the risk of infection, hospitalization, and severe Covid-19. The effectiveness in preventing death was 72% during the period from day 14 through day 20 after the first dose, and hospitalization was reduced by 87% for the period 7 or more days after the second dose, similar to results from a randomized trial.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Immunology

Risk Factors for Severe COVID-19 in Children

Kelly Graff et al.

Summary: This study found that extremes of age, comorbid conditions, and elevated CRP are predictors of severe COVID-19 disease in children. These findings can help pediatric providers and public health officials tailor clinical management and resource allocation strategies more effectively.

PEDIATRIC INFECTIOUS DISEASE JOURNAL (2021)

Add to Collection

Letter Pediatrics

Effect of the new SARS-CoV-2 variant B.1.1.7 on children and young people

Sarah Brookman et al.

LANCET CHILD & ADOLESCENT HEALTH (2021)

Add to Collection

Article Medicine, General & Internal

Effectiveness of BNT162b2 and mRNA-1273 covid-19 vaccines against symptomatic SARS-CoV-2 infection and severe covid-19 outcomes in Ontario, Canada: test negative design study

Hannah Chung et al.

Summary: The study demonstrates that two doses of mRNA covid-19 vaccines are highly effective against symptomatic infection and severe outcomes. However, the effectiveness of one dose is lower, particularly for older adults shortly after the first dose. For adults aged >=70 years, vaccine effectiveness estimates were observed to be lower for intervals shortly after one dose but were comparable to those for younger people for all intervals after 28 days.

BMJ-BRITISH MEDICAL JOURNAL (2021)

Add to Collection

Article Pediatrics

Association Between Race and COVID-19 Outcomes Among 2.6 Million Children in England

Defne Saatci et al.

Summary: This study investigated the association between race and childhood COVID-19 testing and hospital outcomes. It found that there were some race-specific disparities in severe COVID-19 outcomes among children in England.

JAMA PEDIATRICS (2021)

Add to Collection

Article Public, Environmental & Occupational Health

Hospitalizations Associated with COVID-19 Among Children and Adolescents — COVID-NET, 14 States, March 1, 2020–August 14, 2021

Miranda J. Delahoy et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)

Add to Collection

Article Medicine, General & Internal

International Analysis of Electronic Health Records of Children and Youth Hospitalized With COVID-19 Infection in 6 Countries

Florence T. Bourgeois et al.

Summary: This retrospective cohort study analyzed hospitalized pediatric patients with COVID-19 in 6 countries, highlighting variability in hospitalization trends across countries as well as identifying common complications and laboratory abnormalities in infected children and youth.

JAMA NETWORK OPEN (2021)

Add to Collection

Article Medicine, General & Internal

Underlying Medical Conditions Associated With Severe COVID-19 Illness Among Children

Lyudmyla Kompaniyets et al.

Summary: This study investigated the risk of severe COVID-19 illness among children with underlying medical conditions and medical complexity. It found that children with type 1 diabetes, cardiac and circulatory congenital anomalies, and obesity had a higher risk of severe COVID-19 illness, highlighting the importance of close observation and cautious clinical management for these children.

JAMA NETWORK OPEN (2021)

Add to Collection

Letter Medicine, General & Internal

Characteristics of SARS-CoV-2 Infections in Israeli Children During the Circulation of Different SARS-CoV-2 Variants

Ido Somekh et al.

Summary: The cohort study compared the characteristics of SARS-CoV-2 variants infections among children in Israel during two different time periods.

JAMA NETWORK OPEN (2021)

Add to Collection

Review Immunology

SARS-CoV-2 (COVID-19): What Do We Know About Children? A Systematic Review

Nisha S. Mehta et al.

CLINICAL INFECTIOUS DISEASES (2020)

Add to Collection

Article Public, Environmental & Occupational Health

Coronavirus Disease 2019 in Children - United States, February 12-April 2, 2020

Stephanie Bialek et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)

Add to Collection

Article Pediatrics

Epidemiology of COVID-19 Among Children in China

Yuanyuan Dong et al.

PEDIATRICS (2020)

Add to Collection

Review Pediatrics

Clinical manifestations of children with COVID-19: A systematic review

Tiago H. de Souza et al.

PEDIATRIC PULMONOLOGY (2020)

Add to Collection

Review Pediatrics

Clinical characteristics of COVID-19 in children: A systematic review

Jun Yasuhara et al.

PEDIATRIC PULMONOLOGY (2020)

Add to Collection

Review Infectious Diseases

Risk factors for serious outcomes associated with influenza illness in high- versus low- and middle-income countries: Systematic literature review and meta-analysis

Brenda L. Coleman et al.

INFLUENZA AND OTHER RESPIRATORY VIRUSES (2018)

Add to Collection

© Peeref 2019-2024. All rights reserved.